Article Information
History
- February 8, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- aDepartment of Psychology, McGill University, Montreal, QC H3A 1G1, Canada
- bIntegrated Program in Neuroscience, McGill University
- cDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, QC H3A 2B4, Canada
- ↵*Corresponding author: Mario.Bogdanov{at}mail.mcgill.ca
Posted February 08, 2022.
Dopaminergic medication increases motivation to exert cognitive control by reducing subjective effort costs in Parkinson’s patients
